Chemoinformaics analysis of ursodeoxycholic acid
Molecular Weight | 392.58 | nRot | 4 |
Heavy Atom Molecular Weight | 352.26 | nRig | 21 |
Exact Molecular Weight | 392.293 | nRing | 4 |
Solubility: LogS | -4.02 | nHRing | 0 |
Solubility: LogP | 4.26 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 69.9597 |
nHD | 3 | BPOL | 40.9963 |
QED | 0.659 |
Synth | 4.342 |
Natural Product Likeliness | 2.429 |
NR-PPAR-gamma | 0.2 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.99 |
Pgp-sub | 0.979 |
HIA | 0.045 |
CACO-2 | -5.101 |
MDCK | 0.0000259 |
BBB | 0.355 |
PPB | 0.943947 |
VDSS | 0.495 |
FU | 0.038595 |
CYP1A2-inh | 0.035 |
CYP1A2-sub | 0.272 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.781 |
CYP2c9-inh | 0.033 |
CYP2c9-sub | 0.833 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.193 |
CYP3a4-inh | 0.035 |
CYP3a4-sub | 0.076 |
CL | 9.716 |
T12 | 0.907 |
hERG | 0.236 |
Ames | 0.005 |
ROA | 0.023 |
SkinSen | 0.956 |
Carcinogencity | 0.227 |
EI | 0.494 |
Respiratory | 0.924 |
NR-Aromatase | 0.053 |
Antiviral | No |
Prediction | 0.744586 |